Javier Aller
Javier Aller
Hospital Universitario Puerta de Hierro Majadahonda
Dirección de correo verificada de salud.madrid.org
TítuloCitado porAño
Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene
A Cascón, I Comino-Méndez, M Currás-Freixes, AA de Cubas, ...
JNCI: Journal of the National Cancer Institute 107 (5), 2015
1482015
Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients
M Currás-Freixes, L Inglada-Pérez, V Mancikova, C Montero-Conde, ...
Journal of Medical Genetics 52 (10), 647-656, 2015
662015
No clinically significant valvular regurgitation in long‐term cabergoline treatment for prolactinoma
I Halperin, J Aller, C Varela, M Mora, A Abad, A Doltra, AE Santos, ...
Clinical endocrinology 77 (2), 275-280, 2012
302012
Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience
G Crespo, P Jiménez-Fonseca, A Custodio, C López, ...
Future Oncology 13 (7), 615-624, 2017
262017
Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors
P Jiménez-Fonseca, A Carmona-Bayonas, E Martin-Perez, G Crespo, ...
Cancer and Metastasis Reviews 34 (3), 381-400, 2015
252015
PheoSeq: a targeted next-generation sequencing assay for pheochromocytoma and paraganglioma diagnostics
M Currás-Freixes, E Piñeiro-Yañez, C Montero-Conde, M Apellániz-Ruiz, ...
The Journal of Molecular Diagnostics 19 (4), 575-588, 2017
232017
Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in …
R Garcia-Carbonero, R Garcia-Figueiras, A Carmona-Bayonas, I Sevilla, ...
Cancer and Metastasis Reviews 34 (4), 823-842, 2015
222015
Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment
M Campderá, N Palacios, J Aller, R Magallón, P Martín, G Saucedo, ...
Pituitary 19 (2), 158-166, 2016
202016
Results of repeated transsphenoidal surgery in Cushing's disease. Long-term follow-up
P Valderrábano, J Aller, L García-Valdecasas, J García-Uría, L Martín, ...
Endocrinología y Nutrición 61 (4), 176-183, 2014
182014
Escape and lipodystrophy in acromegaly during pegvisomant therapy, a retrospective multicentre S panish study
G Sesmilo, E Resmini, I Bernabeu, J Aller, A Soto, M Mora, A Picó, ...
Clinical endocrinology 81 (6), 883-890, 2014
172014
Influence of RET mutations on the expression of tyrosine kinases in medullary thyroid carcinoma
C Rodriguez-Antona, I Muñoz, L Inglada-Perez, AA de Cubas, ...
Endocrine-related cancer, 2013
172013
Translational research in neuroendocrine tumors: pitfalls and opportunities
J Capdevila, O Casanovas, R Salazar, D Castellano, A Segura, P Fuster, ...
Oncogene 36 (14), 1899, 2017
162017
Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY
I Bernabeu, A Pico, E Venegas, J Aller, JA García-Arnés, M Marazuela, ...
Pituitary 19 (2), 127-137, 2016
162016
Long‐term treatment with pegvisomant for acromegaly: a 10‐year experience
AM Ramos‐Leví, I Bernabeu, C Álvarez‐Escolá, J Aller, T Lucas, ...
Clinical endocrinology 84 (4), 540-550, 2016
122016
Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC)
J Capdevila, JM Trigo, J Aller, JL Manzano, SG Adrián, CZ Llopis, Ò Reig, ...
European journal of endocrinology 177 (4), 309-317, 2017
112017
Recurrent germline dlst mutations in individuals with multiple pheochromocytomas and paragangliomas
L Remacha, D Pirman, CE Mahoney, J Coloma, B Calsina, ...
The American Journal of Human Genetics 104 (4), 651-664, 2019
62019
A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly
PJ Trainer, JDC Newell-Price, J Ayuk, SJB Aylwin, A Rees, W Drake, ...
European journal of endocrinology 179 (2), 97-108, 2018
62018
Spanish Cooperative Group of Neuroendocrine Tumors (GETNE). Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs …
R Garcia-Carbonero, R Garcia-Figueiras, A Carmona-Bayonas, I Sevilla, ...
Cancer Metastasis Rev 34 (4), 823-842, 2015
62015
Thyrotropin reference values in the first trimester of pregnancy
GJ Aller, AA Rabal
Endocrinologia y nutricion: organo de la Sociedad Espanola de Endocrinologia …, 2013
62013
Spanish Neuroendocrine Tumor Group (GETNE). Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors
P Jiménez-Fonseca, A Carmona-Bayonas, E Martín-Pérez, G Crespo, ...
Cancer Metastasis Rev 34 (3), 381-400, 2015
52015
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20